Literature DB >> 22618863

Backbone resonance assignments of the monomeric DUF59 domain of human Fam96a.

Caroline Mas1, Kai-En Chen, Ian M Brereton, Jennifer L Martin, Justine M Hill.   

Abstract

Proteins containing a domain of unknown function 59 (DUF59) appear to have a variety of physiological functions, ranging from iron-sulfur cluster assembly to DNA repair. DUF59 proteins have been found in bacteria, archaea and eukaryotes, however Fam96a and Fam96b are the only mammalian proteins predicted to contain a DUF59 domain. Fam96a is an 18 kDa protein comprised primarily of a DUF59 domain (residues 31-157) and an N-terminal signal peptide (residues 1-27). Interestingly, the DUF59 domain of Fam96a exists as monomeric and dimeric forms in solution, and X-ray crystallography studies of both forms unexpectedly revealed two different domain-swapped dimer structures. Here we report the backbone resonance assignments and secondary structure of the monomeric form of the 127 residue DUF59 domain of human Fam96a. This study provides the basis for further understanding the structural variability exhibited by Fam96a and the mechanism for domain swapping.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618863     DOI: 10.1007/s12104-012-9390-1

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  3 in total

1.  Solution structure of monomeric human FAM96A.

Authors:  Bingjie Ouyang; Lei Wang; Shuo Wan; Yang Luo; Lu Wang; Jian Lin; Bin Xia
Journal:  J Biomol NMR       Date:  2013-06-22       Impact factor: 2.835

2.  FAM96A is a novel pro-apoptotic tumor suppressor in gastrointestinal stromal tumors.

Authors:  Bettina Schwamb; Robert Pick; Sara Beatriz Mateus Fernández; Kirsten Völp; Jan Heering; Volker Dötsch; Susanne Bösser; Jennifer Jung; Rasa Beinoraviciute-Kellner; Josephine Wesely; Inka Zörnig; Matthias Hammerschmidt; Matthias Nowak; Roland Penzel; Kurt Zatloukal; Stefan Joos; Ralf Joachim Rieker; Abbas Agaimy; Stephan Söder; K Marie Reid-Lombardo; Michael L Kendrick; Michael R Bardsley; Yujiro Hayashi; David T Asuzu; Sabriya A Syed; Tamas Ordog; Martin Zörnig
Journal:  Int J Cancer       Date:  2015-03-12       Impact factor: 7.396

3.  Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity.

Authors:  Wan-Peng Wang; Hai-Ying Gao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.